Eric Dobmeier - Nov 10, 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role: Director
Signature: /s/ Jeff Kiekhofer, Attorney-in-Fact
Stock symbol: ATRA
Transactions as of: Nov 10, 2023
Transactions value $: $101,340
Form type: 4
Date filed: 11/14/2023, 06:27 PM
Previous filing: Aug 11, 2023
Next filing: Jun 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRA	Common Stock	Purchase	$101K	+447K	+383.54%	$0.23^*	563K	Nov 10, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2235 to $0.2298. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Content

Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2235 to $0.2298. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.